Back to GetFilings.com



 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C.  20549

 


 

FORM 10-Q

 

ý

 

Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

 

For the Quarter Ended March 31, 2003

 

 

 

 

 

OR

 

 

 

o

 

Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

 

 

Commission File Number 0-11336

 

CIPRICO INC.

(Exact name of Registrant as specified in its charter)

 

DELAWARE

 

41-1749708

(State or other jurisdiction of
incorporation or organization)

 

(I.R.S. Employer
Identification Number)

 

 

 

17400 Medina Road
Plymouth, Minnesota 55447

(Address of principal executive offices)

 

 

 

Registrant’s telephone number, including area code:  (763) 551-4000

 

Indicate by checkmark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.

 

Yes ý  No o

 

The number of shares outstanding of the registrant’s Common Stock, $.01 par value, as of May 1, 2003 was 4,648,678 shares.

 

 



 

CIPRICO INC. AND SUBSIDIARY

 

FORM 10-Q

 

INDEX

 

PART I

Financial Information

 

 

Item 1.

Financial Statements

 

 

 

Condensed Consolidated Balance Sheets at
March 31, 2003 and September 30, 2002

 

 

 

Condensed Consolidated Statements of Operations for Three and
Six-Months Ended March 31, 2003 and 2002

 

 

 

Condensed Consolidated Statements of Cash Flows for
Six-Months Ended March 31, 2003 and 2002

 

 

 

Notes to Condensed Consolidated Financial Statements

 

 

Item 2.

Management’s Discussion and Analysis of Results of Operations and Financial Condition

 

 

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

 

 

Item 4.

Controls and Procedures

 

 

PART II

Other Information

 

 

Item 6.

Exhibits and Reports on Form 8-K

 

SIGNATURES

 

Certifications by CEO Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

Certifications by CFO Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

EXHIBITS

 

Exhibit 99.1

Certifications Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Exhibit 99.2

Certifications Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

2



 

PART I  FINANCIAL INFORMATION

ITEM 1.  FINANCIAL STATEMENTS

 

 

CIPRICO INC. AND SUBSIDIARY

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

 

(In thousands)

 

March 31,
2003

 

September 30,
2002

 

ASSETS

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

8,472

 

$

6,413

 

Marketable securities

 

15,628

 

18,071

 

Accounts receivable, less allowance

 

6,108

 

3,590

 

Inventories

 

4,686

 

3,145

 

Income taxes receivable

 

 

789

 

Other current assets

 

348

 

898

 

Total current assets

 

35,242

 

32,906

 

 

 

 

 

 

 

Property and equipment, net

 

2,743

 

2,608

 

Marketable securities

 

 

2,547

 

Other assets

 

43

 

54

 

 

 

$

38,028

 

$

38,115

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

5,138

 

$

2,724

 

Accrued expenses

 

2,149

 

2,755

 

Deferred revenue

 

386

 

398

 

Total current liabilities

 

7,673

 

5,877

 

 

 

 

 

 

 

Shareholders’ equity:

 

 

 

 

 

Capital stock

 

47

 

48

 

Additional paid-in capital

 

34,671

 

35,188

 

Accumulated Deficit

 

(4,324

)

(2,966

)

Deferred compensation from restricted stock

 

(39

)

(32

)

Total shareholders’ equity

 

30,355

 

32,238

 

 

 

$

38,028

 

$

38,115

 

 

See accompanying notes to condensed consolidated financial statements

 

3



 

CIPRICO INC. AND SUBSIDIARY

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

(In thousands, except
per share amounts)

 

Three-months Ended
March 31,

 

Six-months Ended
March 31,

 

 

2003

 

2002

 

2003

 

2002

 

 

 

 

 

 

 

 

 

 

 

NET SALES

 

$

8,571

 

$

8,110

 

$

16,683

 

$

15,325

 

Cost of sales

 

5,469

 

5,356

 

10,631

 

9,852

 

 

 

 

 

 

 

 

 

 

 

GROSS PROFIT

 

3,102

 

2,754

 

6,052

 

5,473

 

 

 

 

 

 

 

 

 

 

 

OPERATING EXPENSES:

 

 

 

 

 

 

 

 

 

Research and development

 

1,584

 

2,294

 

3,032

 

4,769

 

Sales and marketing

 

1,698

 

2,205

 

3,376

 

4,602

 

General and administrative

 

606

 

670

 

1,278

 

1,311

 

Total operating expenses

 

3,888

 

5,169

 

7,686

 

10,682

 

 

 

 

 

 

 

 

 

 

 

LOSS FROM OPERATIONS

 

(786

)

(2,415

)

(1,634

)

(5,209

)

Other income, primarily interest

 

111

 

236

 

276

 

538

 

 

 

 

 

 

 

 

 

 

 

LOSS BEFORE INCOME TAXES

 

(675

)

(2,179

)

(1,358

)

(4,671

)

Income tax benefit

 

 

(1,130

)

 

(1,130

)

 

 

 

 

 

 

 

 

 

 

NET LOSS

 

$

(675

)

$

(1,049

)

$

(1,358

)

$

(3,541

)

 

 

 

 

 

 

 

 

 

 

Shares used to calculate net loss per share:

 

 

 

 

 

 

 

 

 

Basic and diluted

 

4,658

 

4,904

 

4,685

 

4,919

 

 

 

 

 

 

 

 

 

 

 

NET LOSS PER COMMON SHARE:

 

 

 

 

 

 

 

 

 

Basic and diluted

 

$

(0.14

)

$

(0.21

)

$

(0.29

)

$

(0.72

)

 

See accompanying notes to condensed consolidated financial statements.

 

4



 

CIPRICO INC. AND SUBSIDIARY

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

(In thousands)

 

Six-months Ended
March 31,

 

 

2003

 

2002

 

 

 

 

 

 

 

Cash flows for operating activities:

 

 

 

 

 

Net loss

 

$

(1,358

)

$

(3,541

)

Depreciation and amortization

 

932

 

1,170

 

Changes in operating assets and liabilities

 

(924

)

(1,362

)

 

 

 

 

 

 

NET CASH FLOWS USED IN OPERATING ACTIVITIES

 

(1,350

)

(3,733

)

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

Equipment purchases

 

(1,058

)

(761

)

Purchases of marketable securities

 

(11,088

)

(19,900

)

Proceeds from sale or maturity of marketable securities

 

16,078

 

20,454

 

 

 

 

 

 

 

NET CASH FLOWS PROVIDED BY (USED IN) INVESTING ACTIVITIES

 

3,932

 

(207

)

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

Repurchase of common stock

 

(622

)

(486

)

Proceeds from issuance of common stock

 

99

 

137

 

 

 

 

 

 

 

NET CASH FLOWS USED IN FINANCING ACTIVITIES

 

(523

)

(349

)

 

 

 

 

 

 

Net increase (decrease) in cash and cash equivalents

 

2,059

 

(4,289

)

 

 

 

 

 

 

Cash and cash equivalents at beginning of period

 

6,413

 

6,377

 

 

 

 

 

 

 

Cash and cash equivalents at end of period

 

8,472

 

2,088

 

 

 

 

 

 

 

Marketable securities, current

 

15,628

 

17,986

 

Marketable securities, long-term

 

 

5,098

 

 

 

 

 

 

 

Total cash and marketable securities

 

$

24,100

 

$

25,172

 

 

See accompanying notes to condensed consolidated financial statements.

 

5



 

CIPRICO INC. AND SUBSIDIARY

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

March 31, 2003

(Unaudited)

 

NOTE A – BASIS OF PRESENTATION

 

The principal business activity of Ciprico Inc. and subsidiary (the Company) is the design, manufacture, and marketing of storage and system solutions for digital media applications within the broadcast and entertainment, military and government, and enterprise markets.  The Company’s solutions combine storage, networking and computing technologies to simplify and accelerate digital media workflows. The Company markets its products worldwide through a direct sales force and various distribution channels.

 

In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all necessary adjustments, consisting only of a recurring nature, and disclosures to present fairly the financial position as of March 31, 2003 and the results of operations for the three-month and six-month periods ended March 31, 2003 and 2002, and the cash flows for the six-months ended March 31, 2003 and 2002. The results of operations for the six-months ended March 31, 2003 are not necessarily indicative of the results for the full year.  These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company’s Form 10-K filed on November 5, 2002.

 

In preparation of the Company’s consolidated financial statements, management is required to make estimates and assumptions that affect reported amounts of assets and liabilities and related revenues and expenses. Actual results could differ from the estimates used by management.

 

NOTE B – MARKETABLE SECURITIES

 

The Company has invested its excess cash in commercial paper and government agencies.  These investments are classified as held-to-maturity given the Company’s intent and ability to hold the securities to maturity and are carried at amortized cost.  Investments that have maturities of less than one year have been classified as current marketable securities.

 

At March 31, 2003 and September 30, 2002, amortized cost approximates fair value of held-to-maturity investments, which consist of the following (in thousands):

 

 

 

March 31,
2003

 

September 30,
2002

 

Current marketable securities:

 

 

 

 

 

Commercial Paper

 

$

14,123

 

$

15,568

 

U.S. Government Agencies

 

1,505

 

2,503

 

 

 

15,628

 

18,071

 

Non-current marketable securities:

 

 

 

 

 

Commercial Paper

 

 

1,509

 

U.S. Government Agencies

 

 

1,038

 

 

 

 

2,547

 

 

 

 

 

 

 

 

 

$

15,628

 

$

20,618

 

 

6



 

NOTE C – INVENTORIES

 

Inventory is stated at the lower of cost or replacement market.  Cost is determined using the first-in, first-out method. Inventory costs include outside assembly charges, allocated manufacturing overhead and direct material costs.

 

As of March 31, 2003 and September 30, 2002 inventory consisted of the following (in thousands):

 

 

 

March 31,
2003

 

September 30,
2002

 

 

 

 

 

 

 

Finished Goods

 

$

1,294

 

$

1,158

 

Work-in-Process

 

683

 

292

 

Raw Materials

 

2,709

 

1,695

 

 

 

$

4,686

 

$

3,145

 

 

NOTE D – WARRANTY COSTS

 

The Company provides a three-year warranty on its products.  The Company estimates future warranty claims based on historical experience and anticipated costs to be incurred.  Warranty expense is accrued at the time of sale with an additional accrual for specific items after the sale when their existence is known and amounts are determinable.

 

The following represents a reconciliation of changes in the Company’s accrued warranty as of March 31, 2003 (in thousands):

 

Balance at
September 30, 2002

 

Charged to
Costs and
Expenses

 

Deductions

 

Balance at
March 31, 2003

 

$

502

 

$

81

 

$

96

 

$

487

 

 

NOTE E – INCOME TAXES

 

For the three and six-month periods ended March 31, 2002 the income tax benefit of $1.1 million reflected recognition of an income tax benefit related to an expected Federal income tax refund filed under the provision of the Job Creation and Worker Assistance Act of 2002, enacted on March 9, 2002.   For the three and six-month period ended March 31, 2003 the Company has not recorded an income tax benefit since it has established a valuation allowance against all deferred tax assets.

 

NOTE F – SHAREHOLDERS’ EQUITY

 

Stock Option Plan

 

The Company has a stock option plan under which officers, directors, employees and consultants have been or may be granted incentive and nonqualified stock options to purchase the Company’s common stock at fair market value on the date of grant.  The options become exercisable over varying periods and expire up to 10 years from the date of grant.  The Company applies APB Opinion 25, Accounting for Stock Issued to Employees, and related Interpretations in accounting for its plans.  No stock-based employee compensation cost is reflected in net income, as all options granted under this plan had an exercise price equal to the market value of the underlying common stock on the date of the grant.  The following table illustrates the effect on net income and earnings per share if the Company had applied the fair value recognition provisions of FASB Statement 123, Accounting for Stock-Based Compensation, to stock-based employee compensation.

 

7



 

 

 

 

Three-months Ended
March 31,

 

Six-months Ended
March 31,

 

 

 

2003

 

2002

 

2003

 

2002

 

 

 

 

 

 

 

 

 

 

 

Net loss, as reported

 

$

(675

)

$

(1,049

)

$

(1,358

)

$

(3,541

)

Deduct: Total stock-based employee compensation expense determined under fair value based method for awards granted, modified, or settled, net of related tax effects

 

(107

)

(150

)

(214

)

(300

)

Pro forma net loss

 

$

(782

)

$

(1,199

)

$

(1,572

)

$

(3,841

)

 

 

 

 

 

 

 

 

 

 

Loss per share

 

 

 

 

 

 

 

 

 

Basic and Diluted – as reported

 

$

(0.14

)

$

(0.21

)

$

(0.29

)

$

(0.72

)

Basic and Diluted – pro forma

 

$

(0.17

)

$

(0.24

)

$

(0.34

)

$

(0.78

)

 

Stock Repurchase

 

During 1998, the Company initiated a stock buyback program of up to $6.0 million, which was increased by $6.0 million in 2001, bringing the total amount to be expended under the plan to $12.0 million.  As of March 31, 2003, 1,021,935 shares of common stock have been repurchased for approximately $7.7 million.

 

Stock Option Exchange

 

On December 4, 2002 the Company accepted for exchange stock options to purchase 159,500 shares of common stock granted under the Ciprico Inc. 1999 Amended and Restated Stock Option Plan pursuant to a Tender Offer Statement on Schedule TO dated November 4, 2002 (“Schedule TO”) offered to certain eligible employees (the “exchange”).    The exchange was offered to non-management employees who held stock options effective October 25, 2002 with an exercise price of $7.00 per share or more and expiring after January 1, 2004, who were option holders that had not received options after May 1, 2002.   Subject to the terms and conditions of the exchange, the Company will grant options to purchase an aggregate of 127,600 shares of common stock for such tendered options on or after June 6, 2003 with an exercise price equal to the market value of the Company’s common stock on the date of the grant.  There will be no compensation expense recognized as a result of this exchange.

 

Shareholder Rights Plan

 

On January 8, 2003, the Board of Directors adopted a shareholder rights plan under which the Board declared a dividend distribution of one right for each outstanding share of Ciprico common stock as of January 14, 2003.  Upon becoming exercisable, each right would entitle its holder to buy one one-hundredth of a share of a new series of preferred stock at an exercise price of $32.00 per right.  Subject to certain allowable actions by the Board, the rights will become exercisable if a person or group acquires 15% or more of the Company’s common stock or announces a tender offer for 15% or more of its common stock.  Unless the Board exercises certain other rights, if such a person acquires 15% or more of the Company’s common stock, each right would enable a Ciprico shareholder to acquire Ciprico stock having a market value of twice the right’s exercise price.  The rights are redeemable at the option of the Company in certain instances.

 

8



 

NOTE G – NET LOSS PER SHARE

 

The Company’s basic net loss per share amounts have been computed by dividing net loss by the weighted average number of outstanding common shares.  The Company’s diluted net earnings per share is computed by dividing net earnings by the weighted average number of outstanding common shares and common share equivalents relating to stock options, when dilutive.

 

For the three-month periods ended March 31, 2003 and 2002, common stock equivalents of 57,793 and 67,818 were excluded from the computation of the net loss per share since they were antidilutive due to net losses incurred by the Company.  Options to purchase 833,238 and 1,131,194 shares of common stock with a weighted average exercise price of $8.46 and $9.25 were outstanding at March 31, 2003 and 2002, but were excluded from the computation of common share equivalents for the three-month period because they were antidilutive as the exercise prices were greater than the average market price of the Company’s stock during the period.

 

For the six-month periods ended March 31, 2003 and 2002, common stock equivalents of 22,336 and 42,565 were excluded in the computation of the net loss per share since they were antidilutive due to net losses incurred by the Company.   Options to purchase 799,241 and 1,117,991 shares of common stock with a weighted average exercise price of $8.82 and $9.41 were outstanding at March 31, 2003 and 2002, but were excluded from the computation of common share equivalents for the six-month period because they were antidilutive as the exercise prices were greater than the average market price of the Company’s stock during the period.

 

NOTE H – SEGMENT INFORMATION

 

The Company operates in a single reportable segment.  The Company has no material long-lived assets outside of the United States.  The following presents net sales for the six-months ended March 31, 2003 and 2002 by geographic area (in thousands).

 

Geographic Area

 

2002

 

2003

 

North America

 

$

15,874

 

$

13,458

 

Europe

 

634

 

1,476

 

Other foreign

 

175

 

391

 

 

 

$

16,683

 

$

15,325

 

 

Sales to significant customers as a percentage of sales for the six-month period ended March 31 are as follows:

 

 

 

2003

 

2002

 

Customer A

 

34

%

16

%

Customer B

 

15

 

12

 

Customer C

 

9

 

9

 

Customer D

 

7

 

15

 

Customer E

 

10

 

3

 

 

 

62

%

39

%

 

NOTE I – NEW ACCOUNTING PRONOUNCEMENTS

 

In November 2002, the FASB issued FASB Interpretation No. 45 (FIN 45), Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness of Others.  FIN 45 addresses the disclosure requirements of a guarantor in its interim and annual financial statements about its obligations under certain guarantees that it has issued.  FIN 45 also requires a guarantor to recognize, at the inception of a guarantee, a liability for the fair value of the obligation undertaken in issuing the guarantee.  The disclosure requirements of FIN 45 are effective for the Company beginning

 

9



 

with its quarter ended December 31, 2002.  The liability recognition requirements will be applicable prospectively to all guarantees issued or modified after December 31, 2002.  This pronouncement is not anticipated to have a material effect on the Company’s consolidated financial position or results of operations.  See Note D for disclosure information related to the Company’s warranty program.

 

In January 2003, the FASB issued Interpretation 46 (FIN 46), Consolidation of Variable Interest Entities.FIN 46 is an interpretation of Accounting Research Bulletin No. 51, Consolidated Financial Statements, and addresses consolidation by business enterprises of variable interest entities.  FIN 46 applies immediately to variable interest entities created or obtained after January 31, 2003 and it applies in the first fiscal year or interim period beginning after June 15, 2003, to variable interest entities in which an enterprise holds a variable interest that is acquired before February 1, 2003.  This pronouncement is currently not anticipated to have a material effect on the Company’s consolidated financial position or results of operations.

 

CIPRICO INC. AND SUBSIDIARY

ITEM 2.  MANAGEMENT’S DISCUSSION AND ANALYSIS OF RESULTS OF OPERATIONS AND

FINANCIAL CONDITION

 

Critical Accounting Policies and Estimates

 

Financial Reporting Release No. 60 of the Securities and Exchange Commission, requests that all companies include a discussion of critical accounting policies or methods used in the preparation of financial statements. Note 1 of the Notes to the Consolidated Financial Statements included in the Annual Report on Form 10-K includes a summary of the significant accounting policies and methods used in the preparation of our Consolidated Financial Statements. The following is a brief discussion of the more significant accounting policies and methods used by Ciprico Inc. (“the Company, we and our”).

 

General

 

Management’s discussion and analysis of Ciprico’s financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. The most significant estimates and assumptions relate to the recoverability of receivables and inventories. Actual amounts could differ significantly from these estimates.

 

Revenue Recognition

 

We recognize revenue in accordance with SEC Staff Accounting Bulletin No. 101, “Revenue Recognition in Financial Statements” (“SAB 101”), as amended by SAB 101A and 101B. SAB 101 requires that four basic criteria must be met before revenue can be recognized: (1) persuasive evidence of an arrangement exists; (2) delivery has occurred or services rendered; (3) the fee is fixed and determinable; and (4) collectibility is reasonably assured. Products sold are generally covered by a warranty for periods up to three years. We accrue a warranty reserve within cost of sales for estimated costs to provide warranty services. We estimate the costs to service our warranty obligations based on historical experience and expectation of future conditions.  Revenue from the sale of extended warranty and maintenance agreements is deferred and recognized on a straight-line basis over the term of the related agreement.

 

Accounts Receivable

 

We perform ongoing credit evaluations of our customers and adjust credit limits based upon payment history and the customer’s current credit worthiness, as determined by our review of their current credit information. We continuously monitor collections and payments from our customers and maintain a provision for estimated credit losses based upon our historical experience and any specific customer collection issues that we have identified. While such credit losses have historically been within our expectations and the provisions established, we can not guarantee that we will continue to experience the same credit loss rates that we have in the past. Since our accounts receivable are concentrated in a

 

10



 

relatively few number of customers, a significant change in the liquidity or financial position of any one of these customers could have a material adverse impact on the collectibility of our accounts receivable and our future operating results.

 

Inventories

 

We value our inventory at the lower of the actual cost to purchase and/or manufacture the inventory or the current estimated market value of the inventory. We regularly review inventory quantities on hand and record a provision to reduce excess and obsolete inventory to estimated market value based primarily on our estimated forecast of product demand and production requirements for the next twelve months or expected life of the representative product. A significant decrease in demand could result in an increase in the amount of excess inventory quantities on hand. If actual market conditions are less favorable than those projected by management, additional inventory write-downs may be required. Additionally, our estimates of future product demand may prove to be inaccurate, in which case we may have understated or overstated the provision required for excess and obsolete inventory. If our inventory is determined to be overvalued, we would be required to recognize such costs in our cost of goods sold at the time of such determination.  We do not adjust our lower of cost or market adjustment to inventory components upward once a reduction was determined to be necessary.  We make every effort to ensure the accuracy of our forecasts of future product demand, however any significant unanticipated changes in demand or technological developments could have a significant impact on the value of our inventory and our reported operating results.

 

Warranty

 

Our warranty reserve is established based on our best estimate of the amounts necessary to settle future and existing claims on products sold as of each balance sheet date. While we believe that our warranty reserve is adequate and that our estimate is appropriate, such amounts estimated to be due and payable could differ materially from what will actually transpire in the future.  To the extent we experience increased warranty claim activity or increased costs associated with servicing those claims, we would increase our warranty accrual resulting in decreased gross profit.  Similarly, if the opposite occurs and we experience better than expected results, we would decrease our warranty accrual.

 

Deferred Taxes

 

We record a valuation allowance to reduce our net deferred tax assets to the amount that is more likely than not to be realized. We recognize deferred tax assets and liabilities based on the differences between the financial statement carrying amounts and the tax bases of assets and liabilities. We regularly review the deferred tax assets for recoverability and establish a valuation allowance based on historical taxable income or loss, projected future taxable income or loss, and the expected timing of the reversals of existing temporary differences.

 

The following discussion and analysis of the financial condition and results of operations of Ciprico Inc. and its subsidiary should be read in conjunction with the Condensed Consolidated Financial Statements and the Notes thereto, included elsewhere in this Report.

 

OVERVIEW

 

Ciprico Inc. designs, manufactures and markets storage and system solutions for digital media applications.  Our solutions combine storage, networking and computing technologies to simplify and accelerate digital media workflows. Our primary markets are broadcast and entertainment, which include applications in digital broadcast and film and video production and military and government which include applications involving the data capture, processing and dissemination of surveillance images.  In addition, we have historically sold in other markets with high-performance storage requirements such as geosciences, digital prepress and medical imaging.

 

11



 

CIPRICO INC. AND SUBSIDIARY

ITEM 2.  MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS

OF OPERATIONS

 

RESULTS OF OPERATIONS

 

Three and Six-months Ended March 31, 2003 Compared to Three and Six-months Ended March 31, 2002

 

Comparative information on sales by market for the period ended March 31, are shown in the chart below (in millions).

 

For the Three-months Ended March 31:

 

 

 

2003

 

2002

 

Market

 

Sales

 

% of Total

 

Sales

 

% of Total

 

Broadcast & Entertainment

 

$

6.5

 

76

%

$

4.8

 

59

%

Military & Government

 

2.0

 

23

 

3.0

 

37

 

Other

 

0.1

 

1

 

0.3

 

4

 

Total

 

$

8.6

 

100

%

$

8.1

 

100

%

 

 

 

2003

 

2002

 

Geographic Location

 

Sales

 

% of Total

 

Sales

 

% of Total

 

Domestic

 

$

8.1

 

94

%

$

7.3

 

90

%

International

 

0.5

 

6

 

0.8

 

10

 

Total

 

$

8.6

 

100

%

$

8.1

 

100

%

 

For the Six-months Ended March 31:

 

 

 

2003

 

2002

 

Market

 

Sales

 

% of Total

 

Sales

 

% of Total

 

Broadcast & Entertainment

 

$

11.2

 

67

%

$

7.1

 

46

%

Military & Government

 

5.2

 

31

 

7.5

 

49

 

Other

 

0.3

 

2

 

0.7

 

5

 

Total

 

$

16.7

 

100

%

$

15.3

 

100

%

 

 

 

2003

 

2002

 

Geographic Location

 

Sales

 

% of Total

 

Sales

 

% of Total

 

Domestic

 

$

15.9

 

95

%

$

13.5

 

88

%

International

 

0.8

 

5

 

1.8

 

12

 

Total

 

$

16.7

 

100

%

$

15.3

 

100

%

 

Net sales for the three-month period ended March 31, 2003 increased 6% to $8.6 million compared to $8.1 million for the comparable period in 2002.  Net sales for the six-month period ended March 31, 2003 increased 9% to $16.7 million compared to $15.3 million for the same period last year.  Sales from customers in the United States increased 11% and 18% for the three and six-month periods ended March 31, 2003.  Sales from international customers decreased 38% and 56% for the three and six-month periods ended March 31, 2003.  The overall decline in international sales reflects lower demand from Silicon Graphics Inc. (“SGI”), primarily within our Military segment.

 

Sales in the Broadcast segment increased $1.7 million or 35% and $4.1 million or 58% for the three and six-month periods ended March 31, 2003, respectively.  Substantially all of this increase is a result of higher sales volumes from our top three OEM customers.  We believe this growth reflects growing demand for digital storage applications within the broadcast industry and we believe our sales in the Broadcast segment for fiscal 2003 will be higher than the previous year.  However, this could be adversely impacted by an uncertain sustained economic recovery and / or the potential impacts of the recent military

 

12



 

action in the Middle East that could adversely impact ad spending levels and capital spending in this sector.

 

Sales in the Military segment decreased $1.0 million or 33% and $2.3 million or 31% for the three and six-month periods ended March 31, 2003, respectively.  This decrease reflects reduced spending levels from systems integrators associated with defense related programs due in part to the military action in the Middle East.  Sales in the Military segment have historically fluctuated within periods and are expected to continue to fluctuate in future periods.  The decline in sales in the other market segment primarily reflects reduced demand from several customers in legacy markets such as medical imaging, geosciences and digital prepress.

 

Our revenue growth in fiscal 2003 is dependent on market acceptance of new products, expansion of products into new applications within its targeted market segments, and success of programs which specify Ciprico products.   During 2002, we released three new products including the TALONä, FibreSTOREâ 2210 and DiMedaä 2400.  Total sales of these new products for the six-month period ended March 31, 2003 were approximately $3.5 million.  Sales of our NETarray product attributed to approximately $8.1 million of sales for the first six-month period.

 

Gross profit, as a percentage of net sales, was 36.2% and 36.3% for the three and six-month periods ended March 31, 2003, compared to 34.0% and 35.7% for the same prior year periods.  This increase primarily reflects improved efficiencies and overhead absorption due to increased volumes and the impacts from expense reduction efforts in the prior year.

 

Research and development expenses for the three and six-month periods ended March 31, 2003 were $1.6 million and $3.0 million respectively.  Research and development expenses for the three and six-month periods ended March 31, 2002 were $2.3 million and $4.8 million respectively.  Expenses as a percentage of sales were 18% for both the three and six-months ended March 31, 2003 compared to 28% and 31% for the same prior year periods.  This reduction primarily reflects reduced prototype spending due to the timing of development projects, our shift towards integrated software development activities and decreased headcount due to our restructuring efforts in the prior year.  We expect that quarterly research and development expense levels for the remainder of the year will increase slightly as a result of prototype spending related to our new product development activities.

 

Sales and marketing expenses were $1.7 million and $3.4 million for the three and six-month periods ended March 31, 2003, compared to $2.2 million and $4.6 million for the same prior year periods, a decrease of $500,000 and $1.2 million, respectively.  Expenses as a percentage of sales were 20% for both the three and six-months ended March 31, 2003 compared to 27% and 30% for the same prior year periods.  This reduction is primarily the result of reduced headcount between years resulting from our restructuring efforts during the second half of fiscal 2002.  General and administrative expenses decreased approximately $64,000 and $33,000 for the three and six-month periods ended March 31, 2003, as compared to the same prior year periods.

 

Other income decreased approximately $125,000 and $262,000 for the three and six-month periods ended March 31, 2003, as compared to the same prior year periods. This decrease is due primarily to overall lower investment yields and lower cash and marketable securities balances between periods.

 

An income tax benefit of $1.1 million was recorded in the three and six-month periods ended March 31, 2002.  This benefit reflected recognition of an income tax benefit related to an expected Federal income tax refund filed under the provision of the Job Creation and Worker Assistance Act of 2002, enacted on March 9, 2002.

 

LIQUIDITY AND CAPITAL RESOURCES

 

As of March 31, 2003, we had cash, cash equivalents and marketable securities totaling $24.1 million compared to $27.0 million at the end of fiscal 2002.

 

Cash flows used in operating activities were $1.4 million for the six-months ended March 31, 2003 compared to $3.7 million for the same period last year.  The decrease primarily reflects a reduced operating loss for the period compared to the prior year period.  Capital expenditures of approximately

 

13



 

$1.1 million for the six-months ended March 31, 2003 primarily reflect spending related to our new product development efforts and leasehold improvements related to the relocation of our corporate office.  We anticipate that capital expenditures for fiscal 2003 will approximate $1.7 to $2.0 million.  During the six-months ended March 31, 2003, we purchased 182,895 shares of common stock for approximately $622,000. The remaining authorization as of March 31, 2003 under our stock buyback program is $4.3 million.

 

Please see Note I “New Accounting Pronouncements” for recently issued accounting pronouncements that are applicable to the Company.

 

FORWARD-LOOKING STATEMENTS

 

Certain statements in this Form 10-Q are forward-looking and are subject to various risks and uncertainties, which may cause actual results to differ from the expectations set forth in these forward-looking statements.  Such forward-looking statements, which reflect our current view of future events and financial performance, involve known and unknown risks, which include, but are not limited to, the risk factors set forth in Exhibit 99 on Form 10-K filed on November 5, 2002.  Some of these reasons include the ability to achieve and maintain profitability; the impact of geopolitical and economic factors affecting the markets in which we are concentrated; the impact on revenues and earnings of the timing of product enhancements and new product releases; market acceptance of new products; sales and distribution issues; competition; dependence on suppliers; limited backlog and the historic and recurring pattern of a disproportionate percentage of total quarterly sales occurring the last month and weeks of a quarter.  Investors should take such risks into account when making investment decisions.  Shareholders and other readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date on which they are made.  Ciprico undertakes no obligation to update publicly or revise any forward-looking statements.

 

CIPRICO INC. AND SUBSIDIARY

ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

The Company invests its excess cash in commercial paper and highly rated U.S. government agencies.  All investments are held-to-maturity.  The market risk on such investments is minimal.  Receivables from sales to foreign customers are denominated in U.S. Dollars.  If the currencies of these countries were to fall significantly against the U.S. Dollar, there can be no assurance that such companies would be able to repay the receivables in full. Transactions at the Company’s foreign subsidiary, Ciprico International Limited, are denoted in pounds sterling.  The Company has historically had minimal exposure to changes in foreign currency exchange rates and, as such, has not used derivative financial instruments to manage foreign currency fluctuation risk.

 

CIPRICO INC. AND SUBSIDIARY

ITEM 4.  CONTROLS AND PROCEDURES

 

Ciprico management, including the Chief Executive Officer and Chief Financial Officer, have conducted an evaluation of the effectiveness of disclosure controls and procedures pursuant to Exchange Act Rule 13a-14.  Based on that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that the disclosure controls and procedures are effective in ensuring that all material information required to be filed in this quarterly report has been made known to them in a timely fashion.  There have been no significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date the Chief Executive Officer and Chief Financial Officer completed their evaluation.

 

14



 

CIPRICO INC. AND SUBSIDIARY

PART II - OTHER INFORMATION

 

 

Item 6.  Exhibits and Reports on Form 8-K

(a)

 

Exhibits

 

 

99.1

Certifications Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

99.2

Certifications Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

 

 

(b)

 

Reports on Form 8-K

 

 

A press release issued by Ciprico Inc. on Tuesday, April 22, 2003, disclosing its results of operations for the quarter ended March 31, 2003, pursuant to Item 12 of Form 8-K, “Disclosure of Results of Operations and Financial Condition,” and was included under Item 9 as contemplated by SEC Release No. 33-8216.  The press release was furnished pursuant to Item 9 of Regulation FD.

 

15



 

SIGNATURES

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

CIPRICO INC.

 

 

 

 

Dated:  May 8, 2003

/s/ Robert H. Kill

 

 

Robert H. Kill, President and

 

Chief Executive Officer

 

(Chief Executive Officer)

 

 

 

 

Dated:  May 8, 2003

/s/ Thomas S. Wargolet

 

 

Thomas S. Wargolet, Vice President of

 

Finance/Chief Financial Officer

 

(Principal Financial and Accounting Officer)

 

16



 

CERTIFICATION PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Robert H. Kill, Chief Executive Officer of Ciprico Inc., certify that:

 

1.                                       I have reviewed this quarterly report on Form 10-Q of Ciprico Inc.;

 

2.                                       Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

 

3.                                       Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

 

4.                                       The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

 

a)                                      designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiary, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

 

b)                                     evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the “Evaluation Date”); and

 

c)                                      presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;

 

5.                                       The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function);

 

a)                                      all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and

 

b)                                     any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and

 

6.                                       The registrant’s other certifying officers and I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

 

 

Dated:  May 8, 2003

Signature:

 /s/ Robert H. Kill

 

 

 

 

Robert H. Kill

 

 

 

Chief Executive Officer

 

17



 

CERTIFICATION PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

 

I, Thomas S. Wargolet, Chief Financial Officer of Ciprico Inc., certify that:

 

1.                                       I have reviewed this quarterly report on Form 10-Q of Ciprico Inc.;

 

2.                                       Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

 

3.                                       Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

 

4.                                       The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

 

a)                                      designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiary, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

 

b)                                     evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this quarterly report (the “Evaluation Date”); and

 

c)                                      presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;

 

5.                                       The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function);

 

a)                                      all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and

 

b)                                     any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and

 

6.                                       The registrant’s other certifying officers and I have indicated in this quarterly report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

 

 

Dated:  May 8, 2003

Signature:

 /s/ Thomas S. Wargolet

 

 

 

 

Thomas S. Wargolet

 

 

 

Chief Financial Officer

 

18